|Generate QR code
Open Access
Subscription Access
Derivative Spectrophotometric Methods for Determination of Solifenacin Succinate in Bulk and in Tablet Formulation
Abstract
Rapid, sensitive, reproducible and cost-effective zero-order and first-order derivative spectrophotometric method has been developed for the quantification of solifenacin succinate in bulk and its tablet formulation. Preliminary spectrophotometric determination of the drug was carried out in 0.1 N HCl, methanol and in phosphate buffer pH 2.0 with a total of thirty-three parametric variations. The selected method with three parametric variations employing peak-zero (P-0) and peak-peak (P-P) techniques was assessed for stability, indicating a potential for force-degraded solutions. The method was validated in accordance with the ICH guidelines with respect to linearity, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ), and robustness. Excellent linearity was noted in a concentration range of 1.0–80.0 μg/mL for all three method variants. Limits of detection for the proposed method ranged from 0.03–0.16 μg/mL and limits of quantitation were found to be in the range of 0.09–0.48 μg/mL, respectively. Excellent recovery of the drug was obtained from its marketed tablet formulation with the proposed method.
Keywords
Supporting agencies: We sincerely thank Cipla Limited, Mumbai (India) for graciously providing us pure samples of solifenacin succinate. This work was supported by the University Grants Commission (UGC), New Delhi, India (Grant No. 36/N/296).
About the Authors
P. Singh
University Institute of Pharmaceutical Sciences, UGC Center of Advanced Study, Panjab University
India
India
Chandigarh
A. Bali
University Institute of Pharmaceutical Sciences, UGC Center of Advanced Study, Panjab University
India
India
Chandigarh
References
1. F. J. Morales-Olivas, L. Estañ, Arch. Esp. Urol., 63, No. 1, 43–52 (2010).
2. S. Hoffstetter, F. C. Leong, Expert Opin. Drug Metab. Toxic., 5, No. 3, 345–350 (2009).
3. D. Robinson, L. Cardozo, Therapy, 8, No. 6, 691–701 (2011).
4. R. Reddy, R. Sidhaye, A. Sherikar, M. Nadre, M. Krishna, Pharmacophore, 8, No. 2, 11–23 (2017).
5. N. Desai, S. S. Hussen, K. Arumugam, S. G. Vasanthraju, K. Udupan, Int. J. Pharm. Pharm. Sci., 3, No. 1, 70–74 (2011).
6. V. Bhavana, H. T. Kumar, S. Y. Rao, V. P. K. Rao, Asian J. Pharm. Anal., 9, No. 3, 118–122 (2019).
7. R. P. Shaik, S. B. Puttagunta, C. K. Bannoth, B. S. R. Challa, ISRN Anal. Chem, 1–5 (2014).
8. M. C. Damle, P. C. Rokade, Int. J. Pharm. Sci. Res., 8, No. 4, 218–222 (2016).
9. S. R. Krishna, B. M. Rao, N. S. Rao, J. Chromatogr. Sci., 48, No. 10, 807–810 (2010).
10. H. Terada, Y. Hattori, T. Sasaki, M. Otsuka, Int. J. Pharm., 565, 325–332 (2019).
11. M. A. Tantawy, S. A. Weshahy, M. Wadie, M. R. Rezk, Anal. Methods, 12, No. 26, 3368–3375 (2020).
12. D. Desai, G. Patel, N. Shukla, S. Rajput, Acta Chromatogr., 24, No. 3, 399–418 (2012).
13. B. V. Reddy, B. S. Reddy, N. V. V. S. S. Raman, K. S. Reddy, C. Rambabu, J. Chem., 1–10 (2013).
14. D. K. Singh, M. Kurmi, T. Handa, S. Singh, Chromatographia, 79, No. 3-4, 159–168 (2016).
15. T. C. Akman, Y. Kadıoğlu, Bioorg. Med. Chem., 2, 15–23 (2019).
16. W. G. Ammari, Trop. J. Pharm. Res., 14, No. 5, 845–851 (2015).
17. J. Macek, P. Ptáček, J. J. Klíma, J. Chromatogr. B, 878, No. 31, 3327–3330 (2010).
18. S. B. Puttagunta, R. P. Shaik, C. K. Bannoth, B. S. R. Challa, B. Z. Awen, J. Anal. Sci. Technol., 5, No. 1, 1–8 (2014).
19. T. Yanagihara, T. Aoki, Y. Soeishi, T. Iwatsubo, H. Kamimura, J. Chromatogr. B, 859, No. 2, 241–245 (2007).
20. G. D. Teja, C. D. Dasu, B. P. Srinivasa, P. Ravisankar, J. Chem. Pharm. Sci., 6, No. 3, 195–198 (2013).
21. L. Singh, S. Nanda, Pharm. Methods, 2, No. 1, 21–24 (2011).
22. K.M. Madhu, C. Rambabu, Rasayan J. Chem., 10, No. 4, 1068–1074 (2017).
23. P. Dhara, N. Saiyed, S. Desai, Int. J. Pharm. Pharm. Res., 2, No. 4, 175–183 (2015).
24. B. Rakesh, P. Bhargavi, S. R. Reddy, A. A. Kumar, Int. J. Pharm. Pharm. Sci., 6, No. 10, 190–193 (2014).
25. N. Saiyed, D. Patel, S. Desai, Int. J. Pharm. Pharm. Sci., 2, No. 4, 175–183 (2015).
26. Y. Srinivasarao, H. Kumar, P. Chiranjivi, V. K. Rao, Indian J. Pharm. Sci., 83, No. 2, 331–335 (2021).
27. P. Singh, A. Bali, J. Appl. Spectr., 89, No. 4 (2022) (768–772).
28. ICH, Validation of analytical procedures: text and methodology Q2 (R1), Int. Conference on Harmonization, Geneva, Switzerland, 11, 1–13 (2005).
29. Public assessment report, Scientific discussion, Solifenacin succinate. IS/H/0217-0219/001-002/DC, 3 (2014).
Review
For citations:
Singh P., Bali A. Derivative Spectrophotometric Methods for Determination of Solifenacin Succinate in Bulk and in Tablet Formulation. Zhurnal Prikladnoii Spektroskopii. 2022;89(6):830-835.
Views: 138
Email this article 